MedTruth Begins Sensitization Campaign as FDA Warns of Rare Genital Gangrene Linked to Diabetes Drugs Containing SGLT2

The human health is one of the most important factors demanding proper attention in order to aid proper functioning of the body. Taking into consideration the growing concern for human health, especially with the rise of rare medical conditions, MedTruth was established as a platform which advocates for client’s health and their right to know all there is to know about it. Having shown their commitment to sensitizing visitors about their health over the years, MedTruth has recently embarked on raising awareness following the FDA warning relating rare genital gangrene to diabetes drugs containing SGLT2.

As a consumer health-oriented platform, MedTruth continues to strive to sensitize the entire public, especially with regards to their health in order to ensure that visitors are properly informed of the latest resources and information which can save them from serious medical dangers. As part of their commitment to staying ahead of others and keeping abreast of the latest information in the health and medical world, MedTruth has begun sensitization of visitors especially as the FDA Warns of Rare Genital Gangrene Linked to SGLT2 Diabetes Drugs.

The spokesperson for the medical and consumer health-oriented platform, MedTruth, while describing the platform and its aim said, “MedTruth was established with the aim to track for industry developments and sift through hundreds of thousands of scientific data in order to help you better understand common medical risks. We at MedTruth believe it is your right to know about potential drug dangers, hidden manufacturer histories, and ongoing regulatory actions. We make information sourcing simple by going through mounds of data to give you enough information about each drug and device to prevent future complications. We also have the right resources for the millions of Americans who may have been affected by the side effects of drugs and devices.”

The team at MedTruth have over the years built a community of tested and trusted advocates and a team of legal partners who care deeply about consumers, and recognize each consumer as an individual and not as part of a statistic. Brimming with the commitment to expose and uncover the truth about dangerous drugs and devices while bringing updated and in-depth information to consumers, MedTruth has become the number one movement seeking justice for consumers.

To help millions of Americans stay safe from reported drugs and devices, MedTruth has also compiled a list of harmful and hazardous drugs and devices, including the recently flagged Fournier’s Gangrene SGLT2, to help consumers identify potential medical dangers.

The comprehensive guides at MedTruth begin with the basics, deliver data summaries, and provide rundowns of recent regulations. These guides can be accessed via Medium. MedTruth is located at 811 W. 7th Street 12th Floor, Los Angeles, CA 90017. For inquiries, contact them via phone at (888) 995-2407 or via email at info@medtruth.com. Visit their website for additional information.


Media Contact
Company Name: MedTruth
Contact Person: Mollie Feinberg
Email: Send Email
Phone: (888) 995-2407
Address:811 W. 7th Street 12th Floor
City: Los Angeles
State: California
Country: United States
Website: https://medtruth.com/